Serum total IgE, kU/L, median (IQR)#
|
28.0
(3.5-87.75) |
9.0 (1.0-46.5) |
0.247 |
Serum total IgE ≥60 kU/L,
n, (%)
|
7/24 (29.2%)
|
4/21 (19.0%)
|
0.431
1.75 (0.43-7.10)
|
Specific IgE to inhaled allergens, n, (%)
|
5/22 (22.7%)
|
3/20 (15.0%)
|
0.667
1.67 (0.34-8.10)
|
Specific IgE to food allergens,
n, (%)
|
9/22 (40.9%)
|
7/20 (35.0%)
|
0.694
1.29 (0.37-4.50)
|
Blood eosinophils × 109/L,
median (IQR)&
|
0.43 (0.12-0.70)
|
0.14 (0.07-0.34)
|
0.023
|
Eosinophils ≥ 0.45 × 109/L,
n, (%)
|
10/24 (41.7%)
|
3/22 (13.6%)
|
0.043
5.52 (1.05-19.54)
|
Serum ECP, µg/L,
median (IQR)£
|
4.5 (2.2-9.4)
|
4.5 (2.3-8.0)
|
0.836
|
Nasopharyngeal ECP, ng/g, median (IQR)&
|
347
(171-565) |
498 (216-991) |
0.140 |
Serum ECP ≥16 µg/L,
n, (%)
|
4/25 (16.0%)
|
3/23 (13.0%)
|
0.772
1.27 (0.252-6.40)
|
Nasopharyngeal ECP ≥ 870 ng/g, n, (%)
|
4/23 (17.4%)
|
6/23 (26.1%)
|
0.475
0.60 (01.14-2.48)
|